cyclosporine has been researched along with Hyperglycemia in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (40.91) | 18.2507 |
2000's | 10 (22.73) | 29.6817 |
2010's | 13 (29.55) | 24.3611 |
2020's | 3 (6.82) | 2.80 |
Authors | Studies |
---|---|
Belosludtsev, KN; Belosludtseva, NV; Dubinin, MV; Penkov, NV; Serov, DA; Starinets, VS | 1 |
Chen, M; Chen, Z; Han, B; Liu, X; Yang, C | 1 |
Feige, K; Heinen, A; Hollmann, MW; Huhn, R; Raupach, A; Ruske, R; Stroethoff, M; Torregroza, C; Yueksel, B | 1 |
Carvalho, LR; Castiglia, YM; Deffune, E; Golim, MA; Lemos, SV; Módolo, NS; Nascimento, PD; Souza, AV; Vianna, IG; Vianna, PT | 1 |
Chen, ZR; Guo, HH; Jin, QH; Lu, ZD; Ma, Y | 1 |
He, C; Li, R; Shi, W; Zhang, L | 1 |
Einollahi, B; Kalantar, E; Khalili, N; Rostami, Z | 1 |
Montero, N; Pascual, J | 1 |
Abraham, G; Ali, AA; Mathew, M; Mehra, N; Nagarajan, P; Ramachandran, A; Reddy, PP; Reddy, YN; Sundaram, V | 1 |
Fernandez Nieto, M; Jayne, DR | 1 |
Gasser, A; Hess, RS; Murray, SC | 1 |
Agardh, CD; Agardh, E; Fredrikson, GN; Gomez, MF; González Bosc, LV; Hultgårdh-Nilsson, A; Nilsson, J; Nilsson-Berglund, LM; Nilsson-Ohman, J; Salehi, A; Sigvardsson, M; Smith, ML; Wamhoff, BR; Zetterqvist, AV | 1 |
Hami, M; Mojahedi, MJ; Naghibi, M; Shakeri, MT; Sharifipour, F | 1 |
Catanzaro, OL; Labal, ES; Lauria, LC; Obregon, P; Rodriguez, RR | 1 |
Germini, D; Gonçalves, JE; Neff, CB; Speranzini, MB; Waisberg, DR; Waisberg, J; Zanotto, A | 1 |
Korsgren, O; Tufveson, G; von Zur-Mühlen, B | 1 |
Fujita, K; Kaneko, S; Kusaka, H; Morita, J; Nakamura, S; Nakano, S; Shinde, A | 1 |
Jacob, CK; Job, V; Mathew, JT; Rao, M; Ratnaswamy, S | 1 |
Ahsan, N; Alfrey, EJ; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Leonhardt, M; Light, J; Metzger, R; Mulloy, L; Rocher, L; Scandling, J; Shield, C; Sorensen, J; Stegall, M; VanVeldhuisen, P; Wachs, M | 1 |
Foremny, J; Kalarus, Z; Religia, Z; Szewczyk, M; Zakliczyński, M; Zembala, M; Zielińska, T; Zielińska-Kukla, A | 1 |
Henderson, JD; Lai, CS; Pieper, GM; Roza, AM | 1 |
Heinen, A; Hollmann, MW; Huhn, R; Preckel, B; Schlack, W; Weber, NC | 1 |
Buckels, J; Dmitrewski, J; Krentz, AJ; Mayer, D; McMaster, P; Nattrass, M; Smith, JM | 1 |
Endo, T; Fukao, K; Ishibashi, M; Morozumi, K; Ochiai, T; Ohshima, S; Takahara, S; Takahashi, K; Uchida, K; Yokoyama, I | 1 |
Bechstein, WO; Guckelberger, O; Jonas, S; Knoop, M; Kratschmer, B; Langrehr, JM; Lemmens, HP; Luesebrink, R; Neuhaus, P; Neuhaus, R | 1 |
Hene, RJ; Hermans, J; Hollander, AA; van der Woude, FJ; van Es, LA | 1 |
Elmér, E; Li, PA; Siesjö, BK; Uchino, H | 1 |
Folbergrová, J; Li, PA; Siesjö, BK; Smith, ML; Uchino, H | 1 |
Fritsche, H; Ippoliti, C; Khouri, I; Körbling, M; Przepiorka, D; Warkentin, D; Woo, M | 1 |
Abdulkarim, AB; Elmer, DS; Fraga, D; Gaber, AO; Hathaway, DK; Reddy, K; Shokouh-Amiri, H; Stratta, RJ | 1 |
Kramer, N; Rosenstein, ED; Schneider, G | 1 |
Coles, JG; McCrindle, BW; Walker, RE; West, LJ | 1 |
Bremell, T; Eliasson, B; Eriksson, JW; Fowelin, J; Fredriksson, L; Yu, ZW | 1 |
Dunn, S; Falkenstein, K | 1 |
Antin, JH; Avalos, B; Buell, DN; Christiansen, NP; Devine, SM; Fay, JW; Fitzsimmons, WE; Herzig, RH; Karanes, C; Klein, JL; Litzow, MR; Longo, WL; Maher, RM; Nademanee, A; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; van der Jagt, R; Weisdorf, D; Wingard, JR; Wolff, SN | 1 |
Janelidze, S; Kuroda, S; Siesjö, BK | 1 |
Bartlett, ST; Blahut, S; Cangro, CB; Drachenberg, CB; Fink, JC; Klassen, DK; Papadimitriou, JC; Weir, MR; Wiland, A | 1 |
Buczkowski, AK; Elliott, TG; Landsberg, DN; Levin, A; Scudamore, CH; Sirrs, SM; Tildesley, HD; Yoshida, EM | 1 |
Fujii, S; Hasegawa, T; Hosoi, M; Ishii, T; Miyamoto, M; Mori, T; Sato, T; Tanaka, S; Yamakita, T; Yamamoto, T; Yoshioka, K | 1 |
Bismuth, H; Calne, R; Ericzon, B; Groth, C; McMaster, P; Neuhaus, P; Otto, G; Pichlmayr, R; Williams, R | 1 |
Arita, S; Kasraie, A; Mullen, Y; Ohtsuka, S; Smith, CV; Une, S | 1 |
Boots, JMM; Christiaans, MHL; Nieman, FHM; van Duijnhoven, EM; van Hooff, JP; Wolffenbuttel, BHR | 1 |
Murthy, BV; Prakash, BS; Prasad, TN; Subramanyam, K | 1 |
Asensio Asensio, M; Asensio Sánchez, MJ; Asensio Sanchéz, VM; del Pozo Hernándo, LJ | 1 |
2 review(s) available for cyclosporine and Hyperglycemia
Article | Year |
---|---|
Immunosuppression and Post-transplant Hyperglycemia.
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Everolimus; Graft Rejection; Humans; Hyperglycemia; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation | 2015 |
Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Hyperglycemia; Hyperkalemia; Hypertension; Immunosuppressive Agents; Incidence; Infections; Male; Methylprednisolone; Middle Aged; Patient Compliance; Retrospective Studies; Seizures; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1997 |
7 trial(s) available for cyclosporine and Hyperglycemia
Article | Year |
---|---|
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Topics: Acute Disease; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Florida; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperglycemia; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Probability; Racial Groups; Survival Analysis; Tacrolimus; Time Factors; Tissue Donors | 2003 |
Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group.
Topics: Amylases; Cholesterol; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperglycemia; Kidney; Kidney Transplantation; Potassium; Prednisolone; Survival Rate; Tacrolimus; Time Factors; Triglycerides; Uric Acid | 1995 |
Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Hypercholesterolemia; Hyperglycemia; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Time Factors | 1997 |
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Nuclear Family; Recurrence; Survival Analysis; Tacrolimus; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 1998 |
Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.
Topics: Adult; Biopsy; Cyclosporine; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperplasia; Immunosuppressive Agents; Islets of Langerhans; Male; Microscopy, Electron; Middle Aged; Pancreas Transplantation; Tacrolimus; Time Factors; Transplantation, Homologous; Vacuoles | 1999 |
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cyclosporine; Drug Therapy, Combination; Europe; Female; Glucose; Humans; Hyperglycemia; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Tacrolimus; Time Factors | 1994 |
Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.
Topics: Adult; Aged; Cyclosporine; Diabetes Mellitus; Female; Glucose; Humans; Hyperglycemia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Period; Tacrolimus; Time Factors | 2002 |
35 other study(ies) available for cyclosporine and Hyperglycemia
Article | Year |
---|---|
Alisporivir Normalizes Mitochondrial Function of Primary Mouse Lung Endothelial Cells Under Conditions of Hyperglycemia.
Topics: Animals; Cyclosporine; Endothelial Cells; Glucose; Hyperglycemia; Lung; Mice; Mitochondria; Mitochondrial Permeability Transition Pore; Superoxides; Ubiquitin-Protein Ligases | 2022 |
Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Cyclosporine; Drug Eruptions; Drug Evaluation; Drug Substitution; Female; Humans; Hyperglycemia; Hypertriglyceridemia; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; Renal Insufficiency; Retrospective Studies; Sirolimus; Treatment Outcome | 2020 |
Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia.
Topics: Animals; Cardiotonic Agents; Cyclosporine; Disease Models, Animal; Heart; Hyperglycemia; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Simendan | 2021 |
Cyclosporine A attenuates apoptosis and necrosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic rats.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Apoptosis; Cell Survival; Cyclosporine; Flow Cytometry; Hyperglycemia; Ischemia; Isoflurane; Kidney; Male; Necrosis; Premedication; Propofol; Protective Agents; Random Allocation; Rats, Wistar; Reperfusion Injury; Reproducibility of Results; Time Factors; Treatment Outcome | 2017 |
Therapeutic efficacy of cyclosporin A against spinal cord injury in rats with hyperglycemia.
Topics: Animals; Apoptosis; Apoptosis Inducing Factor; Cyclophilins; Cyclosporine; Disease Models, Animal; Female; Gene Expression Regulation; Hyperglycemia; Interleukin-10; Motor Activity; Nerve Regeneration; Neuroglia; Neurons; Neuroprotective Agents; Peptidyl-Prolyl Isomerase F; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Streptozocin; Tumor Necrosis Factor-alpha | 2018 |
[NFAT2 mediates high glucose-induced apoptosis in glomerular podocytes
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Calcineurin; Cells, Cultured; Cyclosporine; Glucose; Hyperglycemia; Mice; NFATC Transcription Factors; Oligopeptides; Podocytes; Signal Transduction | 2018 |
Hyperglycemia after kidney transplantation: frequency and risk factors.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Chi-Square Distribution; Cholesterol, HDL; Cyclosporine; Female; Humans; Hyperglycemia; Immunosuppressive Agents; Iran; Kidney; Kidney Transplantation; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Young Adult | 2013 |
Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Female; Genetic Predisposition to Disease; Graft Rejection; HLA Antigens; Humans; Hyperglycemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 2015 |
Con: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Kidney; Lupus Nephritis; Mycophenolic Acid | 2016 |
Transient hyperglycaemia in a prediabetic dog treated with prednisone and cyclosporin A.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Prednisone | 2009 |
Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia.
Topics: Animals; Apyrase; Arteries; Binding Sites; Blood Glucose; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disease Models, Animal; Enzyme Inhibitors; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Jurkat Cells; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; NFATC Transcription Factors; Osteopontin; Promoter Regions, Genetic; Pyrazoles; RNA, Messenger; Signal Transduction; Time Factors; Transcriptional Activation; Transfection; Uridine Triphosphate | 2010 |
Cyclosporine trough levels and its side effects in kidney transplant recipients.
Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Headache; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Tremor; Young Adult | 2010 |
Side effects of cyclosporine-A treatment in rats: gingival overgrowth and early hyperglycemia.
Topics: Animals; Blood Glucose; Capillary Permeability; Collagen; Coloring Agents; Cyclosporine; Diabetes Mellitus; Evans Blue; Gingiva; Gingival Overgrowth; Hyperglycemia; Immunosuppressive Agents; Male; Nitric Oxide; Random Allocation; Rats; Rats, Wistar; Time Factors | 2010 |
Pancreatic islet allograft in spleen with immunosuppression with cyclosporine. Experimental model in dogs.
Topics: Animals; Blood Glucose; Cyclosporine; Disease Models, Animal; Dogs; Fasting; Glucose Tolerance Test; Hyperglycemia; Immunosuppression Therapy; Immunosuppressive Agents; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Pancreatectomy; Spleen; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2011 |
Insulin independence after conversion from tacrolimus to cyclosporine in islet transplantation.
Topics: Area Under Curve; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Hyperglycemia; Hypoglycemia; Immune Tolerance; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Middle Aged; Tacrolimus | 2012 |
Prednisolone-sparing effect of cyclosporin A therapy for very elderly patients with myasthenia gravis.
Topics: Aged, 80 and over; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Myasthenia Gravis; Prednisolone; Treatment Outcome | 2013 |
Post-transplant hyperglycaemia: a study of risk factors.
Topics: Adult; Analysis of Variance; Blood Glucose; Body Mass Index; Cyclosporine; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Prednisolone; Renal Dialysis; Risk Factors; ROC Curve | 2003 |
Influence of long term cyclosporine therapy on insulin and its precursors secretion in patients after heart transplantation.
Topics: Blood Glucose; C-Peptide; Creatinine; Cyclosporine; Drug Administration Schedule; Female; Glycated Hemoglobin; Heart Transplantation; Humans; Hyperglycemia; Immunosuppressive Agents; Insulin; Insulin Antagonists; Insulin Secretion; Male; Middle Aged; Postoperative Period; Proinsulin | 2003 |
A dithiocarbamate analogue decreases intraislet cell infiltration and the incidence of diabetes mellitus in the genetic diabetes-prone BB rat.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hyperglycemia; Immunohistochemistry; Immunosuppressive Agents; Insulin; Islets of Langerhans; Lymphocytes; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Inbred BB; Survival Analysis; Thiocarbamates; Time Factors | 2004 |
Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore.
Topics: Animals; Blood Glucose; Blood Pressure; Cardiotonic Agents; Cyclosporine; Drug Administration Schedule; Heart Rate; Hyperglycemia; Male; Methyl Ethers; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Sevoflurane | 2008 |
Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection.
Topics: Cyclosporine; Glucose Intolerance; Graft Rejection; Humans; Hyperglycemia; Liver Transplantation; Tacrolimus | 1994 |
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation?
Topics: Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Cyclosporine; Follow-Up Studies; Humans; Hyperglycemia; Hypertension; Hypertriglyceridemia; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Obesity; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Tacrolimus | 1996 |
Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia.
Topics: Analysis of Variance; Animals; Brain Damage, Chronic; Cerebral Cortex; Cyclosporine; Drug Evaluation, Preclinical; Hippocampus; Hydrogen-Ion Concentration; Hyperglycemia; Immunosuppressive Agents; Ischemic Attack, Transient; Male; Prosencephalon; Rats; Rats, Wistar; Seizures; Substantia Nigra | 1997 |
Changes in the bioenergetic state of rat hippocampus during 2.5 min of ischemia, and prevention of cell damage by cyclosporin A in hyperglycemic subjects.
Topics: Animals; Brain Ischemia; Cyclosporine; Energy Metabolism; Hippocampus; Hyperglycemia; Male; Mitochondria; Necrosis; Permeability; Prosencephalon; Rats; Rats, Wistar | 1997 |
Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts.
Topics: Cyclosporine; Diabetes Complications; Diabetes Mellitus; Drainage; Female; Glucose; Graft Rejection; Humans; Hyperglycemia; Immunosuppressive Agents; Male; Pancreas Transplantation; Portal System; Tacrolimus; Transplantation, Homologous | 1998 |
Refractory hyperglycemia complicating an evolving connective tissue disease: response to cyclosporine.
Topics: Adult; Antibodies; Cyclosporine; Female; Humans; Hyperglycemia; Insulin Resistance; Mixed Connective Tissue Disease; Receptor, Insulin | 1998 |
Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Hyperglycemia; Immunosuppressive Agents; Infant; Lymphoproliferative Disorders; Male; Medical Records; Prednisone; Retrospective Studies; Tacrolimus | 1998 |
Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.
Topics: Adipocytes; Animals; Autoantibodies; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Humans; Hyperglycemia; Immunosuppressive Agents; Insulin; Insulin Resistance; Lupus Erythematosus, Systemic; Middle Aged; Plasmapheresis; Prednisolone; Rats; Receptor, Insulin | 1998 |
Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.
Topics: Administration, Oral; Adolescent; Blood Glucose; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Emulsions; Follow-Up Studies; Humans; Hyperglycemia; Immunosuppressive Agents; Infant; Liver Transplantation; Male; Tacrolimus; Time Factors | 1998 |
The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats.
Topics: Analysis of Variance; Animals; Arterial Occlusive Diseases; Cerebral Infarction; Cyclosporine; Hyperglycemia; Immunosuppressive Agents; Ischemic Attack, Transient; Male; Neuroprotective Agents; Rats; Rats, Wistar; Tacrolimus; Treatment Outcome | 1999 |
Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series.
Topics: Adult; Calcineurin; Cyclosporine; Diabetic Ketoacidosis; Female; Humans; Hyperglycemia; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Tacrolimus | 2000 |
Clinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: a case report.
Topics: Aged; Autoantibodies; Blood Glucose; C-Peptide; Cyclophosphamide; Cyclosporine; Desensitization, Immunologic; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Immunosuppressive Agents; Insulin Resistance; Insulin-Like Growth Factor I; Male; Plasma Exchange; Plasmapheresis; Receptor, Insulin; Syncope | 2000 |
Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
Topics: Animals; Blood Glucose; Body Weight; Cyclosporine; Drug Synergism; Graft Survival; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Immunosuppressive Agents; Islets of Langerhans Transplantation; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pravastatin; Transplantation, Homologous | 2001 |
Postrenal transplant diabetes in conventional and cyclosporine regimens.
Topics: Blood Glucose; Cataract; Cyclosporine; Diabetes Mellitus; Graft Survival; Humans; Hyperglycemia; Hypertension; Kidney Transplantation | 1992 |
[Hyperglycemia caused by cyclosporine A].
Topics: Cyclosporine; Female; Humans; Hyperglycemia; Middle Aged | 1992 |